CN Patent

CN106986861A — 抗病毒化合物

Assigned to AbbVie Bahamas Ltd · Expires 2017-07-28 · 9y expired

What this patent protects

抗病毒化合物。本发明描述了可有效抑制丙型肝炎病毒(“HCV”)复制的化合物。本发明还涉及这种化合物的制备方法、包含这种化合物的组合物和使用这种化合物治疗HCV感染的方法。

USPTO Abstract

抗病毒化合物。本发明描述了可有效抑制丙型肝炎病毒(“HCV”)复制的化合物。本发明还涉及这种化合物的制备方法、包含这种化合物的组合物和使用这种化合物治疗HCV感染的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN106986861A
Jurisdiction
CN
Classification
—
Expires
2017-07-28
Drug substance claim
No
Drug product claim
No
Assignee
AbbVie Bahamas Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.